Stellarex Drug-coated 0.035" angioplasty balloon | Philips Healthcare
Stellarex Drug Coated Angioplasty Balloons – Vascupedia
Philips Launches Two New Stellarex Drug-Coated Balloon Sizes - Medical Product Outsourcing
Philips Fulfills a Prophecy with $2.2B Spectranetics Deal | mddionline.com
Study Results Confirm Safety Of Philips Stellarex .035-Inch Drug-Coated Balloon - Medical Product Outsourcing
mnhuon@baylismedical.com (@HuonNeumann) / Twitter
Stellarex Drug-coated 0.035" angioplasty balloon | Philips Healthcare
Five-year ILLUMENATE results confirm safety profile of Philips Stellarex DCB - Interventional News
mnhuon@baylismedical.com (@HuonNeumann) / Twitter
Stellarex 0.014� OTW Drug-Coated Balloon - Media library | Philips
stellarex - Twitter Search / Twitter
FDA approves Philips' low-dose Stellarex balloons - Drug Delivery Business
Research: These 10 medtech companies care a lot about it
Philips to acquire cardiac device company Spectranetics for €1.9 billion
Philips Stellarex Drug-coated 0.035" Angioplasty Balloon: The Clear DCB Choice - BroadcastMed
Philips Introduces New 200mm and 150mm Stellarex 0.035-inch Low-dose Drug-coated Balloons | DAIC
PTA catheter - Stellarex - Spectranetics - peripheral / balloon / drug eluting
FDA Okays Two Stellarex DCBs for Peripheral Artery Disease
Stellarex Drug Coated Angioplasty Balloons – Vascupedia
Video : Live Case #12: PAOD CTO atherectomy + Stellarex® (Philips)
PDF) Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies
Stellarex Drug-coated 0.035" angioplasty balloon | Philips Healthcare
Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex 0.035 low-dose DCB - Vascular News
Latest data from Philips reinforces the safety profile of Stellarex low-dose DCB - Vascular News
